Patent · US Active

Assay for identification of therapeutics targeting ternary complex formation in protein synthesis

US10174358B2 · kind B2 · utility

0Cited by
0References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 31, 2014
Grant dateJan 8, 2019
Priority date
Expiry dateOct 25, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2500/02
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention provides a novel assay that allows high-throughput screening of chemical compounds for the inhibition of binding between EF-Tu and tRNA.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.